483
North Florida Reproductive Biology LaboratoryFDA 483 - North Florida Reproductive Biology Laboratory - June 28, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of North Florida Reproductive Biology Laboratory in Jacksonville, FL, a human reproductive tissue establishment, identified one observation. The firm failed to adequately screen oocyte donors for disease risks related to xenotransplantation. This indicates a lapse in donor eligibility determination processes.
- Inspection Date
- June 28, 2019
- Product Type
- Biologics
Open in Dashboard
ID · ce4d9582-a93f-4f2d-8005-2924494032dc